Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
Dry and cold. Patchy frost and fog. Good dose of sunshine into Sunday. Kerrie has the detail for the next few days....
Communities say they are still waiting for emergency funding to restore their homes and agricultural land.
A woman is in a critical condition in hospital after she was hit by a taxi in the early hours of Saturday, December 3.